We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+10.68%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$5.73B
AUM Growth
-$32.7M
Cap. Flow
-$304M
Cap. Flow %
-5.3%
Top 10 Hldgs %
52.96%
Holding
258
New
61
Increased
37
Reduced
51
Closed
64

Top Buys

Rank Stock Value
1
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$103M
2
AMZN icon
Amazon
AMZN
+$91.5M
3
BIIB icon
Biogen
BIIB
+$49.7M
4
PARA
Paramount Global Class B
PARA
+$49.7M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$48.3M

Top Sells

Rank Stock Value
1
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$101M
2
ROST icon
Ross Stores
ROST
+$100M
3
FIVE icon
Five Below
FIVE
+$76.2M
4
LULU icon
lululemon athletica
LULU
+$76.1M
5
INCY icon
Incyte
INCY
+$73M

Sector Composition

Rank Sector Weight
1 Healthcare 45.98%
2 Consumer Staples 5.76%
3 Technology 4.46%
4 Consumer Discretionary 4.37%
5 Communication Services 3.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PANW icon
226
Palo Alto Networks
PANW
$297B
– –
-153,600
Closed -$12.6M
PFE icon
227
Pfizer
PFE
$150B
– –
-536,000
Closed -$23.5M
SKX
228
DELISTED
Skechers
SKX
– –
-146,616
Closed -$4.65M
SNAP icon
229
Snap
SNAP
$9.01B
– –
-350,000
Closed -$3.44M
SOBR icon
230
SOBR Safe
SOBR
$1.69M
– –
-1,136
Closed -$3.35M
STKH
231
Steakholder Foods
STKH
$1.28M
– –
-413
Closed -$967K
SWVL icon
232
Swvl Holdings
SWVL
$14.4M
– –
-332,160
Closed -$6.99M
TENX icon
233
Tenax Therapeutics
TENX
$516M
– –
-1,229
Closed -$334K
TGT icon
234
Target
TGT
$66.9B
– –
-300,989
Closed -$44.7M
TRVI icon
235
Trevi Therapeutics
TRVI
$2.59B
– –
-864,000
Closed -$1.33M
TSVT
236
DELISTED
2seventy bio
TSVT
– –
-1,264,000
Closed -$18.4M
TTWO icon
237
Take-Two Interactive
TTWO
$45.1B
– –
-22,000
Closed -$2.4M
TWLO icon
238
Twilio
TWLO
$38.2B
– –
-40,000
Closed -$2.77M
XERS icon
239
Xeris Biopharma Holdings
XERS
$1.34B
– –
-2,504,431
Closed -$3.91M
GTM
240
ZoomInfo Technologies
GTM
$1.2B
– –
-94,000
Closed -$3.92M
ZYME icon
241
Zymeworks
ZYME
$1.75B
– –
-5,785,000
Closed -$35.6M
SNAX
242
DELISTED
Stryve Foods, Inc. Class A Common Stock
SNAX
– –
-44,260
Closed -$352K
DBGIW
243
DELISTED
Digital Brands Group, Inc. Warrant
DBGIW
– –
-7,229
Closed -$43K
BGXX
244
DELISTED
Bright Green Corporation Common Stock
BGXX
– –
-4,761,905
Closed -$5.14M
TARO
245
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
– –
-245,372
Closed -$7.36M
BIOL
246
DELISTED
Biolase, Inc.
BIOL
– –
-6,990
Closed -$1.7M
OPGN
247
DELISTED
OpGen, Inc
OPGN
– –
-26,500
Closed -$1.52M
UPH.WS
248
DELISTED
UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share
UPH.WS
– –
-10,000
Closed -$1K
ELYS
249
DELISTED
Elys Game Technology, Corp. Common Stock
ELYS
– –
-1,986,000
Closed -$943K
VQS
250
DELISTED
VIQ SOLUTIONS INC
VQS
– –
-1,290,663
Closed -$800K
7 8 9
10
11

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q4 2022 Portfolio in Review

As of Q4 2022, Armistice Capital held 258 positions worth $5.73B, down 0.57% from $5.76B the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Armistice Capital withdrew a net $304M in Q4 2022, closing 64 positions and reducing 51 holdings. Its most notable exit was Five Below, an estimated $76.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, up from 43% a quarter earlier, followed by Consumer Staples and Technology.

Against the trend, Armistice Capital opened a new position in CVS Health worth $44.4M.

  • Armistice Capital's largest Q4 2022 buy was CVS Health: 476,000 shares worth $44.4M.
  • Armistice Capital added most to Mirati Therapeutics, Inc. Common Stock in Q4 2022, an estimated $103M increase.
  • Armistice Capital's biggest Q4 2022 reduction was Madrigal Pharmaceuticals, cutting an estimated $101M.
  • Armistice Capital fully exited Five Below in Q4 2022, selling an estimated $76.2M.
  • Armistice Capital's ten largest holdings make up 53% of its $5.73B portfolio in Q4 2022.
  • Armistice Capital opened 61 new positions and closed 64 in Q4 2022.
  • Armistice Capital's portfolio value fell 0.57% quarter-over-quarter to $5.73B.

Based on Armistice Capital's 13F filing for Q4 2022, filed 14 Feb 2023.